Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
61M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
30.7M
-
Shares change
-
+1.57M
-
Total reported value, excl. options
-
$1.21B
-
Value change
-
+$63.2M
-
Number of buys
-
43
-
Number of sells
-
-15
-
Price
-
$39.33
Significant Holders of PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) as of Q1 2021
78 filings reported holding PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2021.
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.7M shares
of 61M outstanding shares and own 50.37% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (5.84M shares), FMR LLC (5.36M shares), Redmile Group, LLC (3.21M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.47M shares), CHI Advisors LLC (2.32M shares), TRV GP IV, LLC (2.13M shares), BlackRock Inc. (1.67M shares), CITADEL ADVISORS LLC (1.22M shares), VANGUARD GROUP INC (1.1M shares), and Farallon Capital Management, L.L.C. (764K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.